you are here: HomeNewsCovishield
covishield
Jump to
195 Results Found
  • COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered May 06, 2021 11:27 AM IST

    COVID-19 | US support for waiving vaccine patents, India’s role and other questions answered

    What does the US decision to support an initiative at WTO for temporary waiver of patent protection for COVID-19 vaccines mean for India? Below is a primer.

  • Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts May 05, 2021 12:43 PM IST

    Open up licensing to develop vaccines and accelerate vaccination drive, demand medical experts

    Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.

  • Serum Institute’s Poonawalla family refused billion-dollar deal in October 2020 - here is why: Report May 05, 2021 10:24 AM IST

    Serum Institute’s Poonawalla family refused billion-dollar deal in October 2020 - here is why: Report

    In September 2020, the Bill and Melinda Gates Foundation provided $150 million to the Pune-based vaccine-maker to fund the additional 10 crore COVID-19 vaccine doses.

  • Covid vaccine production and availability: What we know so far May 04, 2021 02:23 PM IST

    Covid vaccine production and availability: What we know so far

    So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.

  • Full advance of over Rs 1,700 crore released to SII for 11 crore doses of Covishield on April 28: Govt May 03, 2021 03:25 PM IST

    Full advance of over Rs 1,700 crore released to SII for 11 crore doses of Covishield on April 28: Govt

    As on date, against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses have been delivered till May 3, the ministry said, adding, media reports alleging that the Centre has not placed any fresh order for COVID-19 vaccines are "incorrect and not based on facts".

  • COVID-19 vaccine shortage in India will continue till July, says Serum Institute CEO Adar Poonawalla May 03, 2021 02:11 PM IST

    COVID-19 vaccine shortage in India will continue till July, says Serum Institute CEO Adar Poonawalla

    The Serum Institute has been maligned by politicians and critics over the vaccine shortages, Adar Poonawalla tells Financial Times. "I have been victimised very unfairly and wrongly."

  • COVID-19 Vaccine | Covishield production in full swing: Serum Institute of India CEO Adar Poonawalla May 02, 2021 08:32 AM IST

    COVID-19 Vaccine | Covishield production in full swing: Serum Institute of India CEO Adar Poonawalla

    Serum Institute of India CEO Adar Poonawalla also confirmed that he had “an excellent meeting” with all partners and stakeholders in the United Kingdom.

  • Serum Institute plans to start vaccine production outside India May 01, 2021 10:42 AM IST

    Serum Institute plans to start vaccine production outside India

    Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July, later than a previous timeline of end-May.

  • COVID-19 Vaccine Tracker: Over 20 lakh jabbed on April 28, 15.21 crore shots administered so far Apr 30, 2021 11:10 AM IST

    COVID-19 Vaccine Tracker: Over 20 lakh jabbed on April 28, 15.21 crore shots administered so far

    The cumulative number of COVID-19 vaccine doses administered in the country stands at 15,21,05,563.

  • Mumbai stops COVID-19 vaccination drive till May 2 due to shortage of jabs Apr 30, 2021 08:16 AM IST

    Mumbai stops COVID-19 vaccination drive till May 2 due to shortage of jabs

    BMC said the vaccination drive for the 18-44 age group, scheduled to begin from May 1 earlier, was likely to be deferred.

  • COVID-19 vaccine: Centre mulls GST waiver to lower prices Apr 29, 2021 12:28 PM IST

    COVID-19 vaccine: Centre mulls GST waiver to lower prices

    The Centre has decided to open up the vaccination drive for everyone above 18 from May 1 onwards.

  • Home Ministry issues Y category security for Adar Poonawalla Apr 28, 2021 08:01 PM IST

    Home Ministry issues Y category security for Adar Poonawalla

    Poonawalla, 40, is one of the key players in the country's fight against the COVID-19 pandemic.

  • Kerala government to purchase one crore COVID vaccine doses from open market Apr 28, 2021 06:48 PM IST

    Kerala government to purchase one crore COVID vaccine doses from open market

    The state government announced that of the one crore vaccines to be purchased, 70 lakh doses will be Covishield and 30 lakh Covaxin. The said number of doses will be procured between May and July for Rs 483 crore.

  • Covishield prices for states reduced to Rs 300 a dose, says Serum's Adar Poonawalla Apr 28, 2021 05:33 PM IST

    Covishield prices for states reduced to Rs 300 a dose, says Serum's Adar Poonawalla

    The vaccine manufactured by Serum Institute of India was earlier priced at Rs 400 per dose for the state governments.

  • One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet study Apr 28, 2021 04:36 PM IST

    One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet study

    The study also reports a significant decrease of infection rates from 12 to 21 days after the first dose of the Pfizer (58 percent reduction) and AstraZeneca (39 percent reduction) vaccines compared to a control group. The drop in infection at least 21 days after the first dose for Pfizer is 69 percent and for AstraZeneca 60 percent, according to the study.

  • Coronavirus News Highlights: Kerala govt to purchase one crore COVID-19 vaccines Apr 28, 2021 07:34 AM IST

    Coronavirus News Highlights: Kerala govt to purchase one crore COVID-19 vaccines

    Coronavirus News Highlights: Registering a steady increase, the active cases have risen to 29,78,709, comprising 16.55 percent of the total infections

  • Covishield, Covaxin effective against 'Indian strain' of COVID-19, study suggests Apr 27, 2021 10:53 PM IST

    Covishield, Covaxin effective against 'Indian strain' of COVID-19, study suggests

    Anurag Agrawal, the Director of the Institute of Genomics and Integrative Biology (IGIB), said the study on effectiveness of the available vaccines on the B.1.617 variant of SARS-CoV2 suggests that post vaccination, the infections are milder.

  • Lack of transparency in pricing is bad for India’s COVID-19 vaccine drive and economy Apr 27, 2021 03:30 PM IST

    Lack of transparency in pricing is bad for India’s COVID-19 vaccine drive and economy

    If such public money has been used in the development of COVID-19 vaccines, there should be enough transparency in the pricing of these vaccines, too

  • Nepal requests India to fast-track shipment of 10 lakh Covishield doses already paid for Apr 27, 2021 01:10 PM IST

    Nepal requests India to fast-track shipment of 10 lakh Covishield doses already paid for

    As a deadly second wave of COVID-19 continues, Nepal has also requested ventilators, oxygen cylinders and medical supplies from India. Though Nepal has approved a Chinese vaccine, it is not recognised by the WHO and there are concerns over its safety and efficacy.

  • What is the endgame for the second wave? How should investors position themselves? Part-2 Apr 26, 2021 10:35 AM IST

    What is the endgame for the second wave? How should investors position themselves? Part-2

    Given improved demand scenario in developed markets and ebbing of health crises elsewhere, India’s export oriented sectors – IT, pharma and chemicals – are expected to outperform in the short to medium run

  • What is the endgame for the second wave? How should investors position themselves? Part-1 Apr 26, 2021 10:30 AM IST

    What is the endgame for the second wave? How should investors position themselves? Part-1

    Countries having high coverage of COVID jabs have seen a sharp decline in death rates as the vaccination coverage picked up

  • COVID-19 Vaccine | Serum Institute issues clarification on Covishield pricing, says govt procurement is at 'far lower price' Apr 24, 2021 04:18 PM IST

    COVID-19 Vaccine | Serum Institute issues clarification on Covishield pricing, says govt procurement is at 'far lower price'

    "Covishield is the most affordable COVID-19 vaccine available in the market today. The initial prices were kept very low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing," Serum India said in a statement.

  • Explained | How the new vaccination drive is expected to roll out Apr 23, 2021 11:16 AM IST

    Explained | How the new vaccination drive is expected to roll out

    On April 19, the central government announced a major shift in its Covid-19 vaccination strategy. Moneycontrol takes a look at what these changes mean.

  • Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors? Apr 22, 2021 10:14 AM IST

    Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors?

    The year that started out on a sizzling note has fizzled out, with only the pharma sector - naturally - emerging as the top performer, quite like 2020

  • Covishield vaccine's revised prices still only 50% of global rates, says SII CEO Adar Poonawalla Apr 21, 2021 05:36 PM IST

    Covishield vaccine's revised prices still only 50% of global rates, says SII CEO Adar Poonawalla

    SII will never take advantage of the pandemic, we are losing Rs 150 per dose now, says Poonawalla.

Sections